Johnson & Johnson (JNJ) Unloads Entire Elan (ELN) Stake; Says Not Tied to Royalty Pharma Bid
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Klarman's Baupost Sells 2M Shares of Elan (ELN)
June 18, 2013 6:54 AM EDTSeth Klarman's Baupost Group filed 8.3 paperwork on takeover target Elan (NYSE: ELN) under Irish takeover law. The hedge fund showed a 7.1 million share stake, or 1.39% of the outstanding shares. This is down from the 9.1 million share stake held at the end of the last quarter.... More
Royalty Pharma Calls News of Elan (ELN) Sales Process 'Frustrating Tactic'
June 14, 2013 1:40 PM EDTRoyalty Pharma notes today's announcement by Elan Corporation, plc (NYSE: ELN) that it intends to explore a sale of the Company. Royalty Pharma believes it to be a clear frustrating tactic that offers shareholders no certainty that a deal will ever be reached. Royalty Pharma calls on holders of ordinary shares to vote today AGAINST all four resolutions... More
